Vivimed Life Sciences Pvt Ltd Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP Due to the Detection of Trace Amounts of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) Impurity

0
48
FDA Suspends Routine Food Inspections Due to the COVID-19 Pandemic Outbreak
FDA Suspends Routine Food Inspections Due to the COVID-19 Pandemic Outbreak



Vivimed Life Sciences Pvt Ltd (Vivimed) is recalling 19 plenty of Losartan Potassium Tablets USP 25 mg, 50 mg, and 100 mg to client degree. As a result of detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) – that’s above the US Meals & Drug Administration’s interim acceptable exposu



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here